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Comorbid symptoms of depression and
musculoskeletal pain and risk of long term
sickness absence
Ole Melkevik1* , Thomas Clausen1, Jacob Pedersen1, Anne Helene Garde1,3, Andreas Holtermann1,2
and Reiner Rugulies1,3,4
Abstract
Background: Symptoms of depression and musculoskeletal pain have both been found to be associated with increased
risk of long term sickness absence (LTSA). The comorbidity between depression and pain i.e. simultaneous presence of
both symptoms, is well established in the literature. The aim for the current investigation was to investigate whether the
presence of comorbid pain influences the associations between depressive symptoms and LTSA or if the presence of
comorbid depressive symptoms influences associations between musculoskeletal pain and LTSA.
Methods: A sample of 6572 Danish female health care workers responding to a questionnaire about health and working
conditions were followed up in a national register of social transfer payments (DREAM) for 550 days. We estimated the
risk for LTSA of four weeks or more, associated with depressive symptoms and number of musculoskeletal pain locations
using a Cox proportional hazards model allowing multiple observations per individual. We conducted a test for
multiplicative interaction between musculoskeletal pain locations and depressive symptoms, and presented stratified
regression models to facilitate the interpretation of the results.
Results: The severity of depressive symptoms was correlated with the number of pain locations reported (Spearman’s
rho = .24, p < 0.001). We found a significant multiplicative interaction between depressive symptoms and musculoskeletal
pain in predicting the risk of LTSA. Depressive symptoms and number of musculoskeletal pain locations were associated
with increased risk of LTSA for individuals who did not have comorbid symptoms. However, we found no significant
associations between the two predictors and LTSA among participants who reported comorbid symptoms.
Conclusions: The risk of LTSA associated with depressive symptoms and musculoskeletal pain appears to be moderated
by the presence of comorbid symptoms. The modified risk for LTSA among workers with comorbid symptoms requires
further investigation.
Background
Depression and musculoskeletal pain are two well known
risk factors for long term sickness absence (LTSA) i.e.
sickness absence of several weeks [1–5]. Depression is the
fourth leading cause of disability worldwide [6] and has
been found to be associated with increased risk of LTSA,
with some studies showing increased risk even at
sub-clinical levels [1, 4, 7]. Musculoskeletal pain, including
neck/shoulder pain, knee pain and lower back pain, has
been found to be independent risk factors for LTSA [2],
and there is also evidence suggesting that widespread pain
[5], or the number of pain sites [8] are associated with
increased risk factors for LTSA.
The understanding of how depression and pain may
lead to LTSA is complicated by the tendency of pain and
depression to cluster within the same individuals. A re-
view by Bair et al. [9] reported that the level of comor-
bidity varies substantially according to the study
population and the measurements used. On average 65%
of patients with depression experience one or more pain
complaints, ranging from 15 to 100%. Whereas, the
prevalence of patients with pain conditions, who also
experience major depression has been found to vary
between 5 and 85% [9].
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To our knowledge, no studies have yet specifically
addressed whether the risk of LTSA from depressive
symptoms and musculoskeletal pain remains consistent
in the presence of comorbid symptoms. Thus, it is un-
clear if the well-known comorbidity between pain and
depression [9] might be a cause of bias in previous stud-
ies reporting on how depressive symptoms and musculo-
skeletal pain are associated with LTSA in previous
studies [1, 3, 4, 7].
Despite the lack of directly comparable studies, there
are two studies which have results which may be rele-
vant to compare our results to. In a population of older
Americans, Emptage and colleagues [10] found that in-
creasing severity in pain was a stronger predictor of
changes in employment status and onset of work disabil-
ity relative to depression. Having simultaneous symp-
toms of pain and depression was not found to be
associated with significantly different outcomes com-
pared to pain level alone. Demyttenaere and colleagues
[11] utilized a cross sectional study with retrospective
accounts of working days, quality and quantity of work
performance because of problems with physical health
or mental health or use of alcohol or drugs (the work
loss index of the world health organization). They found
that a combination of major depressive episode and
high levels of painful physical symptoms were associ-
ated with a higher work loss score relative to each
disorder alone, but that there was no interaction
between the two risk factors.
The lack of knowledge of whether symptoms of de-
pression and pain interact in predicting the risk of LTSA
has practical implications for the design of interventions
aimed to reduce LTSA. Specifically, if the risk associated
with each risk factor changes (either is amplified or at-
tenuated) with the presence of comorbid symptoms,
then this could imply that specific subgroups are at par-
ticularly high risk, or that comorbid symptoms do not at
all change the risk for LTSA for someone who already
has one risk factor.
In light of the reviewed literature, we expect to find that
pain and depressive symptoms cluster among Danish fe-
male paid care workers. Further, expect to find that crude
models will indicate that both depressive symptoms and
musculoskeletal pain is significantly associated with LTSA.
Finally, we aim to test whether the risk of LTSA associated
with musculoskeletal pain and depressive symptoms re-
spectively, is consistent across levels of the other risk fac-
tor. This test will be explorative, as we do not have
specific expectations regarding the potential interaction.
For the purpose of this investigation, we utilized a cohort
of female paid care workers. This group has previously
been found to be vulnerable to musculoskeletal pain, de-
pressive symptoms and LTSA [2, 12] and may therefore
be suitable for our investigation.
Methods
Sample
This study uses survey-data collected among employees
in the elder-care services in 10 Danish municipalities in
2008–9 linked to a national register on social transfer
payments (the DREAM registry) [13]. The survey was the
third wave of a prospective cohort study. Paper-and-pencil
questionnaires were sent to 13,383 employees and the sur-
vey yielded a response rate of 63.0% (n = 8431). In the ana-
lyses we first excluded participants who were not engaged
in the direct provision of care services (N = 1655) and then
excluded male respondents (N = 204), yielding a final sam-
ple of 6572 respondents. If the response rate is calculated
based upon women who worked in care-providing jobs in
2006, the response-rate is 60%.
Respondents were followed in the DREAM register for
550 days after completion of the survey. DREAM con-
tains weekly information on granted sickness absence
compensation for all citizens and residents in Denmark.
When comparing distributions of depressive symp-
toms, musculoskeletal pain.
age, and job-group from the survey in 2006, we found
no sign of systematic differences between responders
and non-responders of the current sample.
Outcome
LTSA was operationalized as any sickness-absence for
four consecutive weeks or more during the 550 days fol-
lowing the response to the questionnaire. LTSA was
measured in the DREAM register and this absence
period was chosen as it was the shortest possible
absence period we could measure in the DREAM regis-
ter. Respondents who were on sickness absence at the
time of the baseline survey were excluded from the re-
gression models (N = 164) leaving a final sample of 6408
participants. Sickness absence periods that started dur-
ing follow-up and continued after the end of the
follow-up period were included. Respondents who died,
retired or emigrated during follow-up were censored from
the analysis at the time of death, retirement or emigration.
Participants were allowed to contribute with multiple time
periods under risk if they had spells of unemployment, or
if they for any other reason fell temporarily out of the
DREAM registry during time for follow-up.
Predictors
Participants were asked to rate the average levels of
musculoskeletal pain in low back, neck/shoulders and
knees over the last three months. The response scale
ranged from 0 to 9 where 0 was “no pain” and 9 was
“worst imaginable pain”. A drawing from the Nordic
Questionnaire defined the three respective body part re-
gions [14]. We used a cutoff of 3 points on each scale to
indicate whether participants had substantial levels of
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pain. This decision is based upon the work of Andersen
and colleagues [2] where this same instrument was used
and the risk of LTSA was found to increase at 3 points for
pain in the knees, 4 in the /neck shoulders and at 5 in the
lower back. Next, we constructed a count variable indicat-
ing the number of pain locations experienced by each par-
ticipant. This ranged from 0 (no pain) to 3 (pain in all three
assessed body parts). When used as an independent vari-
able in the regression models, this variable was used as
dummy variables with 0 pain locations as a reference value.
Depression was assessed by the Major Depression In-
ventory (MDI) [15]. This scale includes 10 items reflecting
depressive symptoms on a scale from 0 (no symptom ex-
perienced) to 5 (experiencing the symptom all the time).
We included all respondents who answered 5 or more
questions of this scale and generated a mean score which
we multiplied by 10. Thus, the final depression scale had a
theoretical range between 0 and 50. We generated a vari-
able with three levels of depressive symptoms (low: from 0
to 12.99; moderate: from 13 to 20.99, high: from 21 and
more). These categories correspond with the categories
suggested in Olsen et al. [16] where the range of low de-
pressive symptoms are described as no depression/full re-
mission, the medium symptom level is described as
probable major depression/mild depression and the
high symptom level is described as major depression/
moderate depression. The low category serves as a
reference group representing levels of depressive
symptoms which are not likely to be associated with
elevated risk of LTSA. For more in-depth description
of the MDI scale, see Bech et al. [15].
Covariates
We used a set of covariates to adjust analyses for more
precise prediction of risk and to avoid potential confound-
ing. Age (in years) [17, 18] and cohabitation status (yes,
no) [18, 19] were associated with LTSA in previous stud-
ies. Job-title was also included (as dummy variables) as
risk for LTSA has been found to vary across job-groups
[20]. The job-titles included were healthcare assistants,
nursing aids, nurses and therapists, and other care staff.
Finally, seniority at current employer (in years) was in-
cluded as sickness absence has been found to be less com-
mon among individuals with longer seniority [21].
The sensitivity analyses also included controls for
smoking (current smoker, or not), leisure time physical
activity (four levels included as dummy variables) and
physical work demands (a continuous measure assessing
the cumulative physical work from very, very light to
very, very strenuous).
Statistical analysis
We used person chi-square tests and Spearman’s correl-
ation coefficient to assess whether symptoms of
depression and the number of pain locations are inde-
pendent from each other, or if the symptoms tend to
cluster within individuals. We used Cox proportional
hazards models to test for the associations between de-
pression, pain and LTSA. The time scale utilized
counted from the day the questionnaire was completed
until the date when an individual was registered with
LTSA in the DREAM registry, was censored due to
death, retirement or immigration or end of follow-up),
whichever came first. We estimated crude models for
each risk factor, mutually adjusted models (Model 1) and
a mutually adjusted model including covariates (Model
2). Interactions between pain and depression (Model 3)
were tested by including main effects for both number
of pain locations and depression while adding multi-
plicative interaction terms for the effect of pain with
low, medium or high levels of depression. The inter-
action models were tested with statistical adjustment of
age, seniority and cohabitation.
We also performed sensitivity analyses for model 2
and model 3 including additional control variables in-
cluding smoking (current smoker, or not), leisure time
physical activity (four levels included as dummy vari-
ables) and physical work demands (a continuous meas-
ure assessing the cumulative physical work from very,
very light to very, very strenuous). These variables could
potentially confound the associations between depres-
sion, pain and LTSA, but were not included in the
main analyses as they were measured at the same
time as the independent variables, and could therefore
potentially both confound and/or mediate the associa-
tions of interest.
The statistical significance of the interactions was
tested using adjusted Wald tests that tests whether all
multiplicative interaction terms are equal to zero. In case
of significant interactions, we proceeded to explore the
survival models in stratified models. The survival models
were done using the Breslow method for ties and robust
standard errors to account for multiple observations
within some participants. Incidence rates were presented
as the number of cases per 1,000,000 person days. Inter-
actions were interpreted by means of regression models
stratified by both depressive symptoms and the number
of pain locations. All statistical analyses were performed
in STATA/SE (version 15) [22].
Results
The mean age of the participants was 45.9 years (SD =
10.5), the mean level of seniority at the current employer
was 8.3 years (SD = 8.2), and 79.2% of the sample were
cohabiting.
Table 1 shows the distribution of symptoms between
individuals with low, medium and high levels of depres-
sive symptoms across the number of pain locations. The
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distribution of depressive symptoms showed that about
80, 13 and 7% reported low medium and high levels of
depressive symptoms. For the number of pain locations,
we found that about 28% reported 0 pain locations, 27%
reported 1 pain location, 29% reported 2 pain locations,
and 16% reported 3 pain locations. A total of 18% of the
study population have some type of comorbidity includ-
ing one or more pain locations and medium levels of de-
pressive symptoms or higher. There were consistent
patterns indicating that individuals who reported higher
numbers of musculoskeletal pain sites also reported
higher levels of depressive symptoms. This pattern was
confirmed to be non-random as indicated by a signifi-
cant chi-square test X2(6, N = 6246) = 369.52,p < 0.001.
The greatest contribution to the overall chi-square was
from the cells with zero pain locations and 3 pain loca-
tions. When coded as ordinal categorical variables, we
also found a significant bivariate correlation (Spearman’s
rho = .24, p < 0.001).
The lowest incidence rate for LTSA was found for
those who reported low levels of depressive symptoms
and no pain locations (0.22) and the highest incidence
rates were found among participants who reported high
levels of depressive symptoms and no pain locations
(0.65). Participants who reported three pain locations
and high levels of depressive symptoms were also found
to have relatively high incidence rates (0.62). Overall
incidence rates of LTSA increased across levels of symp-
toms for both pain and depression. This was generally
also the case within each stratum of depressive symp-
toms and pain, but with two exceptions. Among
participants with two pain locations, the incidence rates
were highest among those with medium level depressive
symptoms (0.56), and in the high depressive symptom
strata we found that the highest incidence rate was re-
ported among those with no pain locations.
Table 2 shows hazard ratios (HR) and 95% confidence
intervals for the associations between the number of pain
locations, level of depressive symptoms and the risk of
experiencing a spell of LTSA during follow up. The esti-
mates for the crude associations indicate that individuals
who report having pain in one or more locations had an
increased risk of LTSA compared to those who do not
report any pain with HR estimates ranging from 1.52 (1.26
to 1.82) to 2.08 (1.72 to 2.53). There was also a tendency
for increasing risk for LTSA for individuals who reported
pain in multiple locations. Having a medium or high level
of depressive symptoms was also found to be associated
with increased risk of LTSA with HR estimates of 1.31
(1.33 to 1.59) and 1.60 (1.30 to 1.96) respectively. HR esti-
mates for both depressive symptoms and pain attenuated
somewhat with increasing levels of statistical adjustment.
With the exception of medium level of depressive symp-
toms, all risk factors maintained confidence intervals that
did not include unity in both model 1 and model 2.
In model 3, we added multiplicative interaction
terms between depressive symptoms and number of
pain locations. The interaction terms quantify the de-
viation from assumptions of additivity of the inde-
pendent variables. Two of these terms had confidence
intervals with did not include unity (2 pain & high
dep and 3 pain and high dep).
Table 1 The prevalence and percentages of individuals with low, medium and high levels of depressive symptoms across number
of musculoskeletal pain locations at baseline with number of cases and incidence rates for long term sickness absence (LTSA)
Pain Location count low depressive symptoms medium depressive symptoms high depressive symptoms Total
0 91.4 (1598) 5.8 (102) 2.8 (48) 28.0(1748)
cases/incidence rates 166/.22 15/.33 12/.65 194/.24
Chi2 contribution 31.3 72.6 48.9 152.9
1 82.9 (1415) 11.2 (191) 5.9 (100) 27.3(1706)
cases/incidence rates 227/.36 29/.34 21/.52 277/.36
Chi2 contribution 2.6 5.5 4.6 12.6
2 73.7 (1340) 17.1 (311) 9.2 (168) 29.1(1819)
cases/incidence rates 242/.40 69/.56 31/.46 343/.42
Chi2 contribution 7.8 20.2 9.9 37.9
3 62.9 (612) 23.0 (224) 14.1 (137) 15.6(973)
cases/incidence rates 130/.48 45/.47 35/.62 212/.50
Chi2 contribution 33.7 70.0 62.5 166.2
Total 79.5 (4965) 13.3 (828) 7.25 (453) 6246
cases/incidence rates 791/.34 166/.46 105/.55 1070/.36
Chi2 contribution 75.3 168.3 125.9 369.5
X2(6, N = 6246) = 369.52, p < 0.001
Incidence rates are presented in cases pr 1,000,000 person days
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An adjusted Wald test indicated that the overall inter-
action effect was significant X2(6, N = 5251) = 13.61, p <
0.034, suggesting that we can reject the null hypothesis
that all interaction-terms were simultaneously equal
to zero.
Table 3 shows stratified regression models for the as-
sociation between depressive symptoms and LTSA
within each level of pain count with incidence estimates
for all combinations of pain and depressive symptoms.
High levels of depressive symptoms was associated with
a HR of 3.13 (1.59 to 6.21) for participants reporting
high levels of depressive symptoms and no musculoskel-
etal pain. The HR estimates for both medium and high
levels of depressive symptoms were substantially weaker
and not statistically significant among participants who
reported one or more sites of comorbid pain. This was
supported both by the non-significant Wald tests and by
the confidence intervals for medium and high depressive
symptoms that all contained unity.
Table 4 shows stratified regression models for the num-
ber of pain locations across levels of depressive symptoms.
Among participants with low levels of depressive symp-
toms there was an increased risk of LTSA associated with
reporting one or more pain locations. Reporting one pain
location was associated with a HR of 1.58 (1.27 to 1.97),
two pain locations was associated with a HR of 1.64 (1.33
to 2.04) and three pain locations was associated with a HR
of 2.00 (1.55 to 2.56). The number of pain locations was
not associated with LTSA for individuals with medium or
high levels of depressive symptoms. This was indicated
both by confidence intervals which all included unity, and
by non-significant Wald tests for the models.
Table 3 Hazard ratios (HR) and 95% confidence intervals for onset of long term sickness absence (LTSA) within follow up period
across levels of depressive symptoms stratified by the number of pain locations
0 pain locations 1 pain locations 2 pain locations 3 pain locations
Levels of depressive symptoms HR 95% CI HR 95% CI HR 95% CI HR 95% CI
low ref ref ref ref
medium 1.56 (0.87 to 2.78) 0.79 (0.50 to 1.25) 1.30 (0.96 to 1.77) 0.91 (0.62 to 1.32)
high 3.13 (1.59 to 6.21) 1.55 (0.95 to 2.55) 0.97 (0.62 to 1.50) 1.31 (0.87 to 1.98)
Wald(p) for 8 df 20.07(0.01) 12.14(0.15) 8.07(0.09) 12.98(0.11)
Estimates include adjustment for age, seniority and cohabitation and job-group
Table 2 Hazard ratios (HR) and 95% confidence intervals for onset of long term sickness absence (LTSA) within follow up period
across levels of depressive symptoms and number of pain locations
Crude Model 1 Model 2 Model 3
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Number of pain locations
0 ref ref ref ref
1 1.52 (1.26 to 1.82) 1.50 (1.24 to 1.80) 1.44 (1.18 to 1.77) 1.57 (1.26 to 1.95)
2 1.79 (1.50 to 2.13) 1.73 (1.45 to 2.07) 1.56 (1.28 to 1.90) 1.65 (1.33 to 2.04)
3 2.08 (1.72 to 2.53) 1.94 (1.58 to 2.37) 1.81 (1.45 to 2.27) 2.00 (1.56 to 2.57)
Depressive symptoms
low ref ref ref ref
medium 1.31 (1.33 to 1.59) 1.17 (0.98 to 1.40) 1.09 (0.89 to 1.33) 1.52 (0.86 to 2.70)
high 1.60 (1.30 to 1.96) 1.36 (1.10 to 1.70) 1.35 (1.06 to 1.72) 3.07 (1.55 to 6.08)
Interaction terms
1 pain & medium dep 0.52 (0.25 to 1.08)
1 pain & high dep 0.50 (0.22 to 1.16)
2 pain & medium dep 0.86 (0.45 to 1.64)
2 pain & high dep 0.32 (0.14 to 0.71)
3 pain & medium dep 0.61 (0.31 to 1.21)
3 pain & high dep 0.43 (0.19 to 0.96)
Wald(p)/ df dep:62.7(0.00)/2 pain:27.(0.00)/3 74.(0.00)/5 70.81(0.00)/11 81.79(0.00)/17
Model 1: Number of pain locations and depressive symptoms are included in the same model (mutually adjusted)
Model 2: Number of pain locations and depressive symptoms are mutually adjusted and further adjusted for age, seniority and cohabitation
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Sensitivity analyses
We replicated model 2 and model 3 including additional
controls for smoking (current smoker, or not), leisure
time physical activity (four levels included as dummy
variables) and physical work demands (a continuous
measure assessing the cumulative physical work from
very, very light to very, very strenuous). These were not
included in the main models as they could potentially be
mediators for the associations between both pain and
depression and LTSA. The inclusion of these variables
did not change the estimates nor confidence intervals in
any substantial manner relative to those reported in the
main results.
Discussion
The main findings of the current study suggest that as-
sociations between depressive symptoms and musculo-
skeletal pain with LTSA are moderated by the presence
of comorbid symptoms. High depressive symptoms and
reporting one or more pain locations were associated
with increased risk for LTSA among individuals who re-
ported no comorbid symptoms. Neither depressive
symptoms nor the number of musculoskeletal pain loca-
tions were associated with LTSA among individuals who
reported comorbid symptoms. Relatively higher symp-
tom levels of both pain and musculoskeletal pain were
found to be associated with higher probability of comor-
bid symptoms.
The identification of comorbidity between musculoskel-
etal pain and depressive symptoms was expected as this is
widely reported [9, 23, 24]. While many studies utilize lo-
cation specific indicators of musculoskeletal-pain [25–28],
a few other studies also confirm the existence of comor-
bidity when using the number of pain locations as an indi-
cator of the “widespreadness” of pain [29–31]. In total, we
found that 18% of the study population reported some
combination of medium to high levels of depressive symp-
toms and one or more pain locations. Among participants
who reported one or more pain locations, we found that
about 18% reported medium levels of depressive symptoms
and about 10% reported high levels of depressive symp-
toms. For individuals who reported medium to high levels
of depressive symptoms we found that about 88% of these
reported one or more pain locations. Thus, it appears that
while it is common for health care workers to experience
musculoskeletal pain without having depressive symp-
toms, it is less common to experience depressive symp-
toms without also having musculoskeletal pain.
The statistically significant interaction suggests that
the association of depressive symptoms and the number
of pain locations with risk of LTSA is not consistent
across levels of comorbid symptoms. The stratified
models revealed that associations between pain and
LTSA are strong and consistent for individuals with low
levels of depressive symptoms, and that the number of
pain locations is not systematically associated with the
risk of LTSA for participants with medium or high
levels of depressive symptoms. Similarly, reporting
high levels of depressive symptoms was strongly asso-
ciated with the risk of LTSA for individuals with no
reported pain locations, but not among individuals
with one or more pain locations.
There are multiple potential explanations for our find-
ings. One potential explanation is that the relative
change in risk attenuates with secondary/comorbid
symptoms. This would imply that there is a greater rela-
tive change in risk for LTSA when going from being
healthy to having one symptom compared to the
increase in risk from having one, to having two symp-
toms. This explanation appears to be plausible at least
for the most extreme groups where there is a large dif-
ference in incidence rates between the reference group
(no pain locations and low depressive symptoms) and
the highest symptom load for each symptom. The rela-
tive difference in incidence rates is much smaller, or
even negative, when comparing individuals with high
symptom levels of one symptom vs having high levels of
both depressive symptoms and musculoskeletal pain.
There may also be some methodological explanations
for our findings. One such explanation is that the high
levels of both physical and emotional demands in care
work may be too demanding for individuals with both
high symptoms of depression and musculoskeletal pain,
and may lead to these individuals dropping out of this
Table 4 Hazard ratios (HR) and 95% confidence intervals for onset of long term sickness absence (LTSA) within follow up period
across number of pain locations, stratified by levels of depressive symptoms
low depression medium depression high depression
Number of pain locations HR 95% CI HR 95% CI HR 95% CI
0 ref ref ref
1 1.58 (1.27 to 1.97) 0.83 (0.41 to 1.66) 0.80 (0.36 to 1.76)
2 1.64 (1.33 to 2.04) 1.45 (0.79 to 2.67) 0.56 (0.26 to 1.20)
3 2.00 (1.55 to 2.56) 1.26 (0.66 to 2.40) 0.94 (0.44 to 2.00)
Wald(p) for 6 df 54.6(0.00) 10.20(0.33) 14.5(0.11)
Estimates include adjustment for age, seniority and cohabitation and job-group
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line of work. This would imply that the individuals in
our sample, with the highest symptom load, are a rela-
tively selected robust group who are able to stay in their
job despite their high symptoms. It is also possible that
some of the individuals with the most severe symptoms
are assigned to less physically and psychologically
demanding tasks in preventive efforts.
It is important to note that the group with the highest
level of risk (high depressive symptoms and no pain
locations) is a very small group. Indeed, less than 1% of
the total sample reported this combination of symptoms
and only about 10% of individuals with high depression
levels report no pain locations. This relatively low num-
ber of individuals with high symptom levels reduces stat-
istical power, particularly in the medium and high
depression strata. Nevertheless, we remain confident in
the interpretation of the findings in light of the signifi-
cant test of interaction and the consistent difference in
the size of HR estimates between the strata with low
symptom levels (both pain and depression) versus the
other strata.
We were only able to identify two studies which simul-
taneously included depressive symptoms and musculo-
skeletal pain as risk factors for LTSA or similar
outcomes. Emptage and colleagues [10] studied changes
in employment status and onset of work disability and
found that having simultaneous symptoms of pain and
depression was not associated with significantly different
outcomes compared to pain level alone. While this cor-
responds with our findings, it is important to note that
depression alone was not consistently associated with
the outcomes in their study. In a cross-sectional study
based on data from six different European countries,
Demyttenaere and colleagues [11] found that a major
depressive episode and high levels of painful physical
symptoms had additive effects on a work loss days index.
The lack of correspondence with our results may be due
to a range of factors including their use of retrospective
assessment of work-loss days, a sample from six Euro-
pean countries and the inclusion of both men and
women in the analyses. Our study add to this very lim-
ited literature about how combinations of symptoms po-
tentially constitute qualitatively different risk profiles of
work related outcomes relative to studies only including
single risk factors.
Our study has a number of notable strengths including
a relatively large sample of female healthcare profes-
sionals. Thus, our results should generalize well to this
specific occupational group. We also utilized register
based outcomes with a relatively long follow up which
increases the validity of our outcome assessment and
removes any risk of common method bias. Limitations
of the study include the reliance on questionnaire infor-
mation for the symptoms of depression rather than
clinical assessment. The time frame of the questions is
also a limitation as the questions on depressive symp-
toms refers to the last two weeks while the questions on
musculoskeletal pain refer to the last 12 months. Conse-
quently, we cannot be certain whether the symptoms
were present at the same time or if their development
follows a chronological sequence. The fact that the ques-
tionnaire was conducted during work-time also excludes
workers who were sick or unable to be at work the time
of the survey, which could result in a study population
which is healthier than the population we ideally want to
make inference to. The lack of men and different work
groups in the sample may also be considered a limitation
due to limited generalizability of our findings. Finally,
the relatively low response rate could also limit the
generalizability of the prevalence estimates, in particular.
Importantly, this study only includes symptoms of
musculoskeletal pain and depressive symptoms and
does not account for all the other disorders which
have known comorbidity with depression and muscu-
loskeletal pain. It is likely that the number of individ-
uals without comorbidity would be further reduced if
other disorders with known comorbidity with pain
and depressive symptoms would be included. This
includes a number of disorders including anxiety dis-
orders [30, 32, 33], substance abuse disorders [32],
insomnia [34], eating disorders [30, 35], chronic
fatigue and gastrointestinal tract disorders [30].
If future studies identify interactions with other symp-
toms or disorders, then this could imply that traditional
variable oriented analyses may not be appropriate for
the investigation of risk of LTSA. The reason for this is
that testing and interpreting regression models with
three or four way interactions is highly complex and
may be practically unfeasible in most cases. Rather we
would suggest that it may be necessary to assess how
different symptoms typically cluster together in a
cluster-analysis or latent class/profile type of model and
subsequently identify the extent to which these groups
of individuals differ in their risk of LTSA.
Our results have implications for both clinical practice
and occupational medicine/epidemiology. For clinicians,
our findings impliy that it may be appropriate to also
screen or assess clients for musculoskeletal pain upon
the recognition depression, and for depression upon the
recognition of musculoskeletal pain. Our findings also
have implications for occupational epidemiology. The re-
ported interaction between musculoskeletal pain and de-
pressive symptoms imply that studies focusing on the
association between either one of these risk factors and
LTSA may potentially yield misleading results if they ig-
nore or simply control for the other risk factor. This
may be illustrated by comparing the estimates from the
stratified models in Tables 3 and 4, with the estimates
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from model 2. In such a comparison, we find that that
model 2 underestimate associations between depressive
symptoms and LTSA for participants who do not report
comorbid pain. We also find that model 2 overestimates
the association between musculoskeletal pain and risk of
LTSA for individuals with medium or high levels of de-
pressive symptoms.
We suggest that future studies should attempt to repli-
cate our study design to test the validity and generalizability
of our findings. We also encourage studies to investigate
the role of other potential comorbidities, and the mecha-
nisms of why depressive symptoms and musculoskeletal
pain appear to interact in predicting risk of LTSA.
Conclusions
This investigation found that the associations between
depressive symptoms, symptoms of musculoskeletal pain
and LTSA differ for individuals with and without comor-
bid symptoms. The number of pain locations and high
levels of depressive symptoms were associated with in-
creased risk of LTSA among individuals with no comor-
bid symptoms. Neither depressive symptoms nor
musculoskeletal pain were associated with LTSA among
individuals with comorbid symptoms.
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